Haemonetics Anticoagulant Sodium Citrate

Name: Haemonetics Anticoagulant Sodium Citrate

Haemonetics Anticoagulant Sodium Citrate 4% w/v SOLUTION USP

Rx only                        250 mL 

Intended for use only with automated apheresis devices.

Each 100 mL contains: Sodium Citrate (Dihydrate), USP 4.0g 
(pH adjusted with Citric Acid, Monohydrate, USP)

Caution

Not for direct intravenous infusion. The pouch is a moisture barrier. Do not use unless solution is clear and no leaks detected. Single use container. Discard unused portion.

STERILE, nonpyrogenic fluid path.

Room temperature (25°C/77°F). Avoid excess heat. Protect from freezing.

Product code

Product Code 420A
117881-00, Rev. AA-XXX

Haemonetics Corporation
400 Wood Road
Braintree, MA 02184 USA

Product Labeling

Haemonetics Anticoagulant Sodium Citrate  
trisodium citrate dihydrate solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC:57826-420
Route of Administration EXTRACORPOREAL DEA Schedule     
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
TRISODIUM CITRATE DIHYDRATE (ANHYDROUS CITRIC ACID) ANHYDROUS CITRIC ACID 40 mg  in 1 mL
Inactive Ingredients
Ingredient Name Strength
WATER  
Packaging
# Item Code Package Description
1 NDC:57826-420-02 250 mL in 1 BAG
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA BN980123 01/10/2013
Labeler - Haemonetics Corporation (942344649)
Revised: 10/2017   Haemonetics Corporation
Share
(web3)